Clinical Trials
Showing 133–143 of 143 results
-
Post-marketing Safety Market Overview and Outlook
$4,900.00 – $7,350.00 -
The Phase I Market Overview and Outlook
$4,900.00 – $7,350.00 -
CRO Quality Benchmarking Report (3rd edition)
$6,800.00 – $10,200.00 -
CRO Selection for Small Pharma and Biotech (2011)
$2,460.00 – $3,690.00 -
EDC and ePRO Market Overview and Outlook
$4,900.00 – $7,350.00 -
Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators
$4,900.00 – $7,350.00 -
The State of the Central Lab Market
$2,460.00 – $3,690.00 -
CRO Quality Benchmarking (2nd edition)
$6,800.00 – $10,200.00 -
Late Phase Market Overview and Outlook (2010)
$6,800.00 – $10,200.00 -
Patient and Investigator Recruitment Success
$4,900.00 – $7,350.00 -
CRO Quality Benchmarking Report (1st edition)
$4,800.00 – $7,200.00